The MICs of 21 P-lactam antibiotics were measured against 126 clinically significant and epidemiologically unrelated Yersinia enterocoEltica isolates. The most active antimicrobial agents tested (geometric means of MICs) were ceftriaxone, cefotaxime, ceftizoxime, and cefmenoxime (0.06 to 0.08 ,ug/ml). Mezlocillin (1.36 ig/ml) and piperacillin (1.57 ,ug/ml) were the most active penicillins. Aztreonam (5, 8-11, 17, 21, 30, 31), and the entire species was considered to be resistant to these 1-lactam antibiotics (23). Different patterns of ,B-lactam resistance were reported according to serotype (1, 5, 9, 10, 28).
Since 1967, Yersinia enterocolitica clinical isolates have been reported to be resistant to ampicillin, cephalothin, and related 1-lactam antibiotics (5, 8-11, 17, 21, 30, 31) , and the entire species was considered to be resistant to these 1-lactam antibiotics (23) . Different patterns of ,B-lactam resistance were reported according to serotype (1, 5, 9, 10, 28) .
Several 1-lactamases including 1-lactamases A and B were found to be produced by Y. enterocolitica strains (3) (4) (5) and associated with serotypes (3, 14) . Production of 3-lactamase is a resistance mechanism which could explain the clinical inefficiency of 1-lactamase-hydrolyzable antibiotics such as ampicillin and cephalothin against Y. enterocolitica infections (15, 20, 25) .
The recent availability of newer ,B-lactam antibiotics not actually hydrolyzed by ,B-lactamases gave rise to a renewed interest for these antibiotics. Marked in vitro activity of some newer 1-lactam antibiotics against Y. enterocolitica isolates has been reported (16, 24, 26, 29) .
The purposes of the present study were to (i) determine comparatively the MICs of 21 PCA of MIC data. Antibiotics that gave rather uniform MICs were not retained in the analysis. MICs of six antibiotics (ampicillin, carbenicillin, cephalothin, cephaloridine, cephalexin, and cefoxitin) were used for PCA. Of the six principal components (axes) computed, three were significant (P < 0.05) and explained 88% of the total variance. The two first axes were very significant (P < 0.005) and explained 82% of the total variance. These two axes are sufficient to display the relationship among the data (Fig. 1) . Although the serotypes were not included in the data for PCA, it appears ( Fig. 1 ) that strains are clustered by serotype. The susceptibility of four major serotypes (03, 09, 08, and 05,27) to the six P-lactam antibiotics used in the PCA is shown ( Table 4) . Each of the four major serotypes has a specific pattern of susceptibility. (5, 21) or diffusion method (1, 10, 17, 28) . All strains in our sample showed some level of resistance to ampicillin and cephalothin, irrespective of the serotype or geographical origin. This confirms results from other studies (9, 11, 23, 30, 31) . The susceptibility of all of the isolates to newer antibiotics such as ureidopenicillins, carbapenems, monobactams, and thirdgeneration cephalosporins appeared homogenous and particularly high for cephalosporins, as reported by other authors (16, 24, 26, 29) .
Resistance to ampicillin or cephalothin has been associated with bacterial production of 3-lactamase(s) (5, 27, 31) .
It was shown that at least two types of P-lactamases, called A and B by Cornelis and Abraham (3, 4) and Matthew et al. (14) , were produced by Y. enterocolitica strains. In our sample, all strains produced at least one 3-lactamase. Positive iodometric detection with benzylpenicillin and ampicillin as substrates, and high synergism demonstrated for clavulanic acid and sulbactam in combination with carbenicillin (decrease of MIC of seven dilution factors), suggested that most of the strains tested (106) produced at least a penicillinase-type enzyme like 1-lactamase A. This powerful synergy of clavulanic acid in combination with carbenicillin could appear contradictory to data reported on a poor potentiation effect between clavulanic acid and ampicillin against Y. enterocolitica strains (6) . However, the ampicillin resistance also could be mediated by a cephalosporinasetype 3-lactamase, and clavulanic acid is less effective against this type of enzyme (19, 22) .
In the 20-carbenicillin-susceptible strains, another type of 1-lactamase was demonstrated by the iodometric procedure (positive with benzylpenicillin and negative with ampicillin), which could be a cephalosporinase-type enzyme like 1B-lactamase B (3, 4) . This enzyme seemed to be produced in all of the isolates (M. J. Hornstein, M. R. Scavizzi, and A. M. Philippon, unpublished data).
The dispersion of MICs of six 1-lactams was used for PCA. The fact that PCA yielded several clusters (corresponding to the different major serotypes) might suggest different mechanisms of resistance for these clusters. Strains in the core of each cluster can be sampled for use in a study of these resistance mechanisms.
Only imipenem expressed an excellent in vitro bactericidal activity on the basis of MBC/MIC (ratio = 1) and MBC values (cO.5 ,ug/ml). For the other newer 3-lactams, this ratio expressed in dilution factors was calculated to be 4 to 8. MBCs of third-generation cephalosporins were not more than 8 ,ug/ml (except cefotetan and ceftazidime), whereas MBCs of newer penicillins and aztreonam reached 128 and 256 ,tg/ml. Since the 3-lactam family has pharmacological advantages, the concept of therapy with newer 1-lactam antibiotics may prove to be a useful alternative. Therapeutical experiments with infected laboratory animals are needed before newer 13-lactams can be recommended in the treatment of human Y. enterocolitica infections.
